Key facts
- This page summarizes J. E. Davis's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 Mar 2022, 15:36.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Tax liability
Additional SEC filing notes
Footnote F1
Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d).
Footnote F2
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.